The paper by Nitzkorski and colleagues determined that age, stage at diagnosis, and race were independent predictors of survival after diagnosis of rectal cancer.
The paper by Nitzkorski and colleagues determined that age, stage at diagnosis, and race were independent predictors of survival after diagnosis of rectal cancer. 1 They suggested that factors other than socioeconomic status might explain why blacks had lower survival rates than whites.
Overlooked in the discussion was vitamin D status. Higher serum 25-hydroxyvitamin D [25(OH)D] levels at time of diagnosis of colorectal cancer were found associated with lower mortality rates. Those in the highest quartile of 25(OH)D [mean value, 40.0 ng/ml) had an adjusted hazard ratio of 0.52 [95% confidence interval (CI), 0.29-0.94] for overall mortality compared with those in the lowest quartile (mean value, 16.5 ng/ml). 2 Colon and rectal cancer mortality rates have similar geographical variations in the United States with respect to solar ultraviolet-B doses, an index of vitamin D production, and often are combined due to the lower numbers of rectal cancer cases. 3 The role of vitamin D status in explaining black-white disparities in survival rates after diagnosis of cancer was reviewed recently. 4 Eleven types of cancer have been found to have black-white disparities in survival rates after consideration of socioeconomic status, stage at diagnosis, and treatment. Elderly black Americans have serum 25(OH)D levels near 16-17 ng/ml, whereas elderly white Americans have serum 25(OH)D levels near 25 ng/ml. 5 Based on serum 25(OH)D level-colon cancer incidence rate relations, the difference is thought to be responsible for approximately a 25% difference in survival rates, which is within the range of 10-102% found by Nitzkorski et al. 1 . Perhaps Nitzkorski and colleagues can add consideration of vitamin D in their future studies of rectal cancer outcome disparities.
